NFSG
IMUX icon

Newbridge Financial Services Group’s Immunic IMUX Stock Holding History

Newbridge Financial Services Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$750 – 1233
2023
Q4 		$750 Hold
50
– – ﹤0.01% 1035
2023
Q3 		$735 Hold
50
– – ﹤0.01% 1178
2023
Q2 		$1.25K Hold
50
– – ﹤0.01% 1191
2023
Q1 		$745 Hold
50
– – ﹤0.01% 1296
2022
Q4 		$700 Hold
50
– – ﹤0.01% 1335
2022
Q3 		$2K Hold
50
– – ﹤0.01% 1204
2022
Q2 		$2K Hold
50
– – ﹤0.01% 1185
2022
Q1 		$6K Hold
50
– – ﹤0.01% 1060
2021
Q4 		$5K Buy
+50
New +$4.5K ﹤0.01% 1069

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Newbridge Financial Services Group's IMUX Position: Q1 2024 in Review

Newbridge Financial Services Group sold out of Immunic (IMUX) in Q1 2024, closing a stake of 50 shares — an estimated $750 sold.

Newbridge Financial Services Group first reported a position in IMUX in Q4 2021 and held it in 9 quarters. The position peaked at $6K in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q1 2024.

  • Newbridge Financial Services Group reported no remaining Immunic position as of Q1 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 50 Immunic shares in Q1 2024, an estimated $750.
  • Newbridge Financial Services Group first reported a position in Immunic in Q4 2021 and held it in 9 quarters.
  • Newbridge Financial Services Group's Immunic position peaked at $6K in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q1 2024.

Based on Newbridge Financial Services Group's 13F filing for Q1 2024, filed 24 Apr 2024.